Danny Hart

2017

In 2017, Danny Hart earned a total compensation of $3.1M as Vice President, Business Development at PDL BioPharma, a 121% increase compared to previous year.

Compensation breakdown

Salary$308,987
Stock Awards$406,000
Other$2,340,438
Total$3,055,425

Hart received $2.3M in other compensation, accounting for 77% of the total pay in 2017.

Hart also received $309K in salary and $406K in stock awards.

Rankings

In 2017, Danny Hart's compensation ranked 3,559th out of 14,666 executives tracked by ExecPay. In other words, Hart earned more than 75.7% of executives.

ClassificationRankingPercentile
All
3,559
out of 14,666
76th
Division
Manufacturing
1,227
out of 5,772
79th
Major group
Chemicals And Allied Products
340
out of 2,075
84th
Industry group
Drugs
261
out of 1,731
85th
Industry
Biological Products, Except Diagnostic Substances
49
out of 313
84th
Source: SEC filing on April 26, 2018.

Hart's colleagues

We found five more compensation records of executives who worked with Danny Hart at PDL BioPharma in 2017.

2017

John McLaughlin

PDL BioPharma

Chief Executive Officer

2017

Dominique Monnet

PDL BioPharma

President

2017

Peter Garcia

PDL BioPharma

Chief Financial Officer

2017

Christopher Stone

PDL BioPharma

General Counsel

2017

Steffen Pietzke

PDL BioPharma

Chief Accounting Officer

You may also like